Literature DB >> 15374802

Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital cardiac disease.

Harald Kaemmerer1, Sohrab Fratz, Siegfried L Braun, Klaus Koelling, Andreas Eicken, Silke Brodherr-Heberlein, Klaus Pietrzik, John Hess.   

Abstract

A high percentage of cyanotic adults (37%) with cyanotic congenital cardiac disease (CCD) presented with depleted iron stores (13 of 52) or latent iron deficiency (6 of 52), even in a CCD center in which cyanotic patient phlebotomy is mostly avoided. In many of these patients, hypochromia and microcytosis was frequent, whereas hyperchromia and macrocytosis were relatively common.Furthermore, 50% of patients presented with hyperhomocysteinemia, possibly related to folate or B vitamin deficiencies, which may increase red blood cell size and color, explaining the lack of microcytosis and hypochromia in many cyanotic patients with iron deficiency.

Entities:  

Mesh:

Year:  2004        PMID: 15374802     DOI: 10.1016/j.amjcard.2004.06.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

2.  The adult patient with eisenmenger syndrome: a medical update after dana point part I: epidemiology, clinical aspects and diagnostic options.

Authors:  Harald Kaemmerer; Siegrun Mebus; Ingram Schulze-Neick; Andreas Eicken; Pedro T Trindade; Alfred Hager; Erwin Oechslin; Koichiro Niwa; Irene Lang; John Hess
Journal:  Curr Cardiol Rev       Date:  2010-11

3.  Elevated red cell distribution width is associated with delayed postoperative recovery after correction of Tetralogy of Fallot.

Authors:  Shine Kumar; Abish Sudhakar; Maitreyi Mohan; Rakhi Balachandran; Benedict Raj; Sunil Gopalraj Sumangala; R Krishna Kumar
Journal:  Ann Pediatr Cardiol       Date:  2013-07

Review 4.  Pulmonary hypertension in congenital heart disease.

Authors:  Emma Pascall; Robert Mr Tulloh
Journal:  Future Cardiol       Date:  2018-05-24

5.  Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension.

Authors:  Luke S G E Howard; Geoffrey M J Watson; John Wharton; Christopher J Rhodes; Kakit Chan; Rajeshree Khengar; Peter A Robbins; David G Kiely; Robin Condliffe; Charlie A Elliott; Joanna Pepke-Zaba; Karen Sheares; Nicholas W Morrell; Rachel Davies; Deborah Ashby; J Simon R Gibbs; Martin R Wilkins
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

6.  Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease.

Authors:  R Condliffe; P Clift; K Dimopoulos; R M R Tulloh
Journal:  Pulm Circ       Date:  2018-07-23       Impact factor: 3.017

7.  Serum Iron Status of Children with Cyanotic Congenital Heart Disease in Lagos, Nigeria.

Authors:  Adejumoke Y Itiola; Barakat A Animasahun; Olisamedua F Njokanma
Journal:  Sultan Qaboos Univ Med J       Date:  2019-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.